Reset filters
  • 20 September 2007

ICAAC: Dapivirine safe and tolerable as potential vaginal microbicide; displays potential in combination with other agents

Read the article
  • 20 September 2007

ICAAC: 48-week results show maraviroc still potent in highly treatment-experienced

Read the article
  • 19 September 2007

ICAAC: Gardasil provides some protection against wide spectrum of cancer-causing HPV

Read the article
  • 19 September 2007

ICAAC: Dual/mixed tropic virus speeds disease progression as much as tenfold increase in viral load

Read the article
  • 19 September 2007

ICAAC: In NNRTI-based regimens, stepwise discontinuation minimises risk of antiretroviral resistance

Read the article
  • 19 September 2007

ICAAC: Boosted darunavir non-inferior to boosted lopinavir after 48 weeks in treatment-naïve

Read the article
  • 19 September 2007

ICAAC: Vicriviroc safe, effective after 2 years, phase III studies start soon

Read the article
  • 19 September 2007

ICAAC: Raltegravir shows sustained effect in highly treatment-experienced patients

Read the article
  • 19 September 2007

ICAAC: Best response to elvitegravir seen when used with T-20 and other active agents

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.